EMILY RUSSELL: Open Payments
NPI 1457874216 · FLORENCE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 36 payments from 10 companies in 2025. Trend: 2023 $266 · 2024 $394 · 2025 $617
Food & beverage: $617
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $159 |
| ABBVIE INC. | 11 | $137 |
| Antares Pharma, Inc. | 4 | $111 |
| Novo Nordisk Inc | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| IBSA Pharma Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: XYOSTED, MOUNJARO, ZEPBOUND, QULIPTA, Wegovy, UBRELVY, FARXIGA, TRINTELLIX.
Industry payments across AL — which companies pay providers there.
